Evidence map›Paper›PMID 38894584›Full record

ArticleJournal of biomedical materials research. Part A2024

3D printed scaffolds with quercetin and vitamin D3 nanocarriers: In vitro cellular evaluation.

Susmita Bose, Vishal Sharad Chaudhari, Priya Kushram

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. EnhancedACS applied bio materials · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Impact of Vitamin DJournal of functional biomaterials · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Susmita BoseW. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, Washington, USA.ORCID 0000-0001-8601-016X
Vishal Sharad ChaudhariW. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, Washington, USA.
Priya KushramW. M. Keck Biomedical Materials Research Laboratory, School of Mechanical and Materials Engineering, Washington State University, Pullman, Washington, USA.

Funding

3D Printed Calcium Phosphate Scaffolds with Natural Medicinal Compounds for Dental ApplicationsR01DE029204 · NIDCR · WASHINGTON STATE UNIVERSITY · PI BOSE, SUSMITA · 2020 to 2024
$1.7M
National Institute of Dental and Craniofacial Research (NIDCR) of the NIH R01 DE029204-01NIDCR NIH HHS R01 DE029204
6 · The paper itself

Abstract

Increasing bone diseases and anomalies significantly challenge bone regeneration, necessitating the development of innovative implantable devices for effective healing. This study explores the potential of 3D-printed calcium phosphate (CaP) scaffolds functionalized with natural medicine to address this issue. Specifically, quercetin and vitamin D3 (QVD) encapsulated solid lipid nanoparticles (QVD-SLNs) are incorporated into the scaffold to enhance bone regeneration. The melt emulsification method is utilized to achieve high drug encapsulation efficiency (~98%) and controlled biphasic release kinetics. The process-structure-property performance of these systems allows more controlled release while maintaining healthy cell-material interactions. The functionalized scaffolds show ~1.3- and ~-1.6-fold increase in osteoblast cell proliferation and differentiation, respectively, as compared with the control. The treated scaffold demonstrates a reduction in osteoclastic activity as compared with the control. The QVD-SLN-loaded scaffolds show ~4.2-fold in vitro chemopreventive potential against osteosarcoma cells. Bacterial assessment with both Staphylococcus aureus and Pseudomonas aeruginosa shows a significant reduction in bacterial colony growth over the treated scaffold. These findings summarize that the release of QVD-SLNs through a 3D-printed CaP scaffold can treat various bone-related disorders for low or non-load-bearing applications.

Indexed as

CholecalciferolNanoparticlesPrinting, Three-DimensionalQuercetinTissue ScaffoldsCalcium PhosphatesCell Line, TumorCell ProliferationDrug CarriersHumansOsteoblastsPseudomonas aeruginosaStaphylococcus aureusCalcium PhosphatesCholecalciferolDrug CarriersQuercetin3D‐printed scaffoldlipid nanoparticlesquercetinvitamin D3

Identifiers

PMID38894584
PMCPMC11464199

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.